-
Something wrong with this record ?
Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017
M. Shahrezaee, S. Keshtkari, M. Moradi-Lakeh, M. Abbasifard, V. Alipour, S. Amini, J. Arabloo, A. Arzani, M. Bakhshaei, A. Barzegar, A. Bijani, M. Dianatinasab, S. Eskandarieh, RG. Gheshlagh, A. Ghashghaee, R. Heidari-Soureshjani, SSN. Irvani, A....
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Global Health MeSH
- Global Burden of Disease * MeSH
- Quality-Adjusted Life Years MeSH
- Humans MeSH
- Musculoskeletal Diseases * epidemiology MeSH
- Life Expectancy MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Iran MeSH
Musculoskeletal diseases (MSDs) are the leading cause of disability and facing them demands updated reports on their burden for efficient policymaking. We showed Iran had the highest female-to-male ratio and highest increase in the burden of musculoskeletal diseases, in the past three decades, worldwide. We further confirmed the role of population aging as the main cause. PURPOSE: MSDs comprise most of the top causes of years lived with disability (YLDs) worldwide and are rapidly increasing in lower- and middle-income countries. Here, we present disability and mortality due to MSDs in Iran at the national level from 1990 to 2017. METHODS: We used Global Burden of Disease (GBD) 2017 Study data and standard methodology and presented the burden of MSDs in rates of years of life lost (YLLs), YLDs, and disability-adjusted life years (DALYs) during 1990-2017, for population aged ≥ 5 years old. We further explored attributable risk factors and decomposed the changing trend in DALYs to assess underlying causes. RESULTS: In Iran, MSDs were responsible for 1.82 million (95%uncertainty interval [UI] 1.3-2.4) DALYs, in 2017. During the past 28 years, with 1.75% annualized percentage change (APC), Iran had the highest percentage increase in the all-ages MSD DALYs rate worldwide, while the age-standardized DALYs APC was negligible. Low back pain was the greatest contributor to DALYs and caused 4.5% of total DALYs. The female population is experiencing considerably higher burden of MSDs, with 115% and 48% higher all-ages YLLs and YLDs rates per 100,000, respectively (YLLs 28.7; YLDs 2629.1), than males (YLLs 13.2; YLDs 1766.1). However, due to wide UIs, difference was not significant. Only 17.6% of MSD YLDs are attributable to assessed risk factors. CONCLUSION: Despite that MSDs are rising as an important cause of disability in Iran, these conditions are not sufficiently addressed in health policies. There is urgent need for cross-sectoral engagement, especially addressing the MSDs in females.
1st Faculty of Medicine Charles University Prague Czech Republic
Department of Anesthesiology Hamedan University of Medical Sciences Hamadan Iran
Department of Epidemiology and Biostatistics Tehran University of Medical Sciences Tehran Iran
Department of Epidemiology Arak University of Medical Sciences Arak Iran
Department of Health Services Management Arak University of Medical Sciences Arak Iran
Department of Internal Medicine AJA University of Medical Sciences Tehran Iran
Department of Orthopedic Surgery AJA University of Medical Sciences Tehran Iran
Department of Parasitology and Mycology Shiraz University of Medical Sciences Shiraz Iran
Department of Plastic Surgery Iran University of Medical Sciences Tehran Iran
Faculty of Nursing and Midwifery Kurdistan University of Medical Sciences Sanandaj Iran
Health Management and Economics Research Center Iran University of Medical Sciences Tehran Iran
Health Policy Research Center Shiraz University of Medical Sciences Shiraz Iran
Nursing Care Research Center Semnan University of Medical Sciences Semnan Iran
Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran
School of Behavioral Sciences and Mental Health Iran University of Medical Sciences Tehran Iran
School of Nursing and Midwifery Tehran University of Medical Sciences Tehran Iran
School of Rehabilitation Sciences Kermanshah University of Medical Sciences Kermanshah Iran
Social Determinants of Health Research Center Babol University of Medical Sciences Babol Iran
Student Research Committee Babol University of Medical Sciences Babol Iran
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028017
- 003
- CZ-PrNML
- 005
- 20210114152815.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11657-020-00767-8 $2 doi
- 035 __
- $a (PubMed)32651719
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Shahrezaee, M $u Department of Orthopedic Surgery, AJA University of Medical Sciences, Tehran, Iran.
- 245 10
- $a Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017 / $c M. Shahrezaee, S. Keshtkari, M. Moradi-Lakeh, M. Abbasifard, V. Alipour, S. Amini, J. Arabloo, A. Arzani, M. Bakhshaei, A. Barzegar, A. Bijani, M. Dianatinasab, S. Eskandarieh, RG. Gheshlagh, A. Ghashghaee, R. Heidari-Soureshjani, SSN. Irvani, A. Lahimchi, S. Maleki, N. Manafi, A. Manafi, MA. Mansournia, A. Mohammadian-Hafshejani, MAM. Bandpei, R. Moradzadeh, M. Naderi, K. Pakshir, A. Rafiei, V. Rashedi, N. Rezaei, A. Rezapour, MA. Sahraian, S. Shahabi, M. Shamsi, A. Soheili, A. Soroush, M. Zamani, B. Mohajer, F. Farzadfar,
- 520 9_
- $a Musculoskeletal diseases (MSDs) are the leading cause of disability and facing them demands updated reports on their burden for efficient policymaking. We showed Iran had the highest female-to-male ratio and highest increase in the burden of musculoskeletal diseases, in the past three decades, worldwide. We further confirmed the role of population aging as the main cause. PURPOSE: MSDs comprise most of the top causes of years lived with disability (YLDs) worldwide and are rapidly increasing in lower- and middle-income countries. Here, we present disability and mortality due to MSDs in Iran at the national level from 1990 to 2017. METHODS: We used Global Burden of Disease (GBD) 2017 Study data and standard methodology and presented the burden of MSDs in rates of years of life lost (YLLs), YLDs, and disability-adjusted life years (DALYs) during 1990-2017, for population aged ≥ 5 years old. We further explored attributable risk factors and decomposed the changing trend in DALYs to assess underlying causes. RESULTS: In Iran, MSDs were responsible for 1.82 million (95%uncertainty interval [UI] 1.3-2.4) DALYs, in 2017. During the past 28 years, with 1.75% annualized percentage change (APC), Iran had the highest percentage increase in the all-ages MSD DALYs rate worldwide, while the age-standardized DALYs APC was negligible. Low back pain was the greatest contributor to DALYs and caused 4.5% of total DALYs. The female population is experiencing considerably higher burden of MSDs, with 115% and 48% higher all-ages YLLs and YLDs rates per 100,000, respectively (YLLs 28.7; YLDs 2629.1), than males (YLLs 13.2; YLDs 1766.1). However, due to wide UIs, difference was not significant. Only 17.6% of MSD YLDs are attributable to assessed risk factors. CONCLUSION: Despite that MSDs are rising as an important cause of disability in Iran, these conditions are not sufficiently addressed in health policies. There is urgent need for cross-sectoral engagement, especially addressing the MSDs in females.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a globální zátěž nemocemi $7 D000071219
- 650 _2
- $a celosvětové zdraví $7 D014943
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a naděje dožití $7 D008017
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a muskuloskeletální nemoci $x epidemiologie $7 D009140
- 650 _2
- $a kvalitativně upravené roky života $7 D019057
- 651 _2
- $a Írán $x epidemiologie $7 D007492
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Keshtkari, S $u Department of Internal Medicine, AJA University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Moradi-Lakeh, M $u Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Abbasifard, M $u Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Clinical Research Development Unit, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
- 700 1_
- $a Alipour, V $u Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran. Department of Health Economics, Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Amini, S $u Department of Health Services Management, Arak University of Medical Sciences, Arak, Iran.
- 700 1_
- $a Arabloo, J $u Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Arzani, A $u Center for Non-Communicable Pediatric Diseases, Health Research Institute, School of Nursing and Midwifery, Babol University of Medical Sciences, Babol, Iran.
- 700 1_
- $a Bakhshaei, M $u Department of Anesthesiology, Hamedan University of Medical Sciences, Hamadan, Iran.
- 700 1_
- $a Barzegar, A $u Department of Occupational Health Engineering, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- 700 1_
- $a Bijani, A $u Social Determinants of Health Research Center, Babol University of Medical Sciences, Babol, Iran.
- 700 1_
- $a Dianatinasab, M $u Department of Epidemiology, Shahroud University of Medical Sciences, Shahroud, Iran. Department of Epidemiology, Shiraz University of Medical Sciences, Shiraz, Iran.
- 700 1_
- $a Eskandarieh, S $u Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Gheshlagh, R Ghanei $u Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran.
- 700 1_
- $a Ghashghaee, A $u Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran. Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Heidari-Soureshjani, R $u School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Irvani, S S N $u Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Lahimchi, A $u First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Maleki, S $u Clinical Research Development Center, Taleghani and Imam Ali Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- 700 1_
- $a Manafi, N $u Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada. Department of Ophthalmology, Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Manafi, A $u Department of Plastic Surgery, Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Mansournia, M A $u Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Mohammadian-Hafshejani, A $u Department of Epidemiology and Biostatistics, Shahrekord University of Medical Sciences, Shahrekord, Iran.
- 700 1_
- $a Bandpei, M A Mohseni $u Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
- 700 1_
- $a Moradzadeh, R $u Department of Epidemiology, Arak University of Medical Sciences, Arak, Iran.
- 700 1_
- $a Naderi, M $u Clinical Research Development Center, Taleghani and Imam Ali Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- 700 1_
- $a Pakshir, K $u Department of Parasitology and Mycology, Shiraz University of Medical Sciences, Shiraz, Iran.
- 700 1_
- $a Rafiei, A $u Department of Immunology, Mazandaran University of Medical Sciences, Sari, Iran. Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
- 700 1_
- $a Rashedi, V $u School of Behavioral Sciences and Mental Health (Tehran Institute of Psychiatry), Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Rezaei, N $u Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
- 700 1_
- $a Rezapour, A $u Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Sahraian, M A $u Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Shahabi, S $u Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- 700 1_
- $a Shamsi, M $u School of Rehabilitation Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- 700 1_
- $a Soheili, A $u Nursing Care Research Center, Semnan University of Medical Sciences, Semnan, Iran.
- 700 1_
- $a Soroush, A $u School of Rehabilitation Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- 700 1_
- $a Zamani, M $u Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
- 700 1_
- $a Mohajer, B $u Department of Orthopedic Surgery, AJA University of Medical Sciences, Tehran, Iran. b.mohajer@ncdrc.info.
- 700 1_
- $a Farzadfar, F $u Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. f-farzadfar@tums.ac.ir.
- 773 0_
- $w MED00194989 $t Archives of osteoporosis $x 1862-3514 $g Roč. 15, č. 1 (2020), s. 103
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32651719 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152812 $b ABA008
- 999 __
- $a ok $b bmc $g 1608352 $s 1119197
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 15 $c 1 $d 103 $e 20200710 $i 1862-3514 $m Archives of osteoporosis $n Arch Osteoporos $x MED00194989
- LZP __
- $a Pubmed-20210105
